en

PRODUCT DETAIL

BELKYRA 10 mg/ml

Code 1534C
MA number 46/0463/16-S
Product Form: sol inj 4x2 ml/20 mg (liek.inj.skl.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 46 - DERMATOLOGICA
ATC:
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AX Other dermatologicals
D11AX24 Deoxycholic acid
Shelf life: 30
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 27.10.2016
Validity: 26.06.2026
Pediatric posology: Yes
PIL: PIL_BELKYRA 10 mg-ml_10.2022.pdf  
SPC: SPC_BELKYRA 10 mg-ml_10.2022.pdf  
Safety feature Yes
Data update: 15.12.2021
eu-flag.png sk-flag.png